Register / Log In

Hospital/Health-System Pharmacy

The few words that change everything
Some thoughts about the things that count
Long-term data reinforce safety profile of dabigatran
Results from the RELY-ABLE trial, the RE-LY extension study, support the long-term safety profile of dabigatran etexilate mesylate (Pradaxa, Boehringer Ingelheim Pharmaceuticals) 150 mg twice daily in patients with nonvalvular atrial fibrillation (NVAF), according to a study published in Circulation in mid-June.
Tennessee pharmacy board strengthens compounding rules
Less than a month after FDA warned of an outbreak following steroid injections from a compounding pharmacy there, the Tennessee Board of Pharmacy (TBOP) strengthened its oversight of compounding pharmacies.
Anticoagulant dosing in obesity should be individualized and drug-specific

FDA approves sublingual agent for treatment of opioid dependence

Pharmacology and therapeutics of pain medications: Part 2
New CPE Series: June activity available now
USPSTF advises against vitamin D, calcium to prevent fractures in healthy adults
After its recent review, the U.S. Preventive Services Task Force (USPSTF) could not recommend vitamin D and calcium supplementation for the primary prevention of fractures in healthy adults.
Pharmacist-driven MTM could save ACOs a bundle
Pharmacists are becoming consultants, medication managers, and more in the coordinated care environment of ACOs
Compounding after the meningitis tragedy: NCPA responds
NCPA is working with healthcare leaders in Congress to ensure development of appropriate measures
Managed Medicaid captures almost half of fee-for-service Rxs, shifts patient care
IMS study analyzes the shift from fee-for-service in four states through changes in prescriptions for antipsychotic drugs, diabetes therapies, and respiratory medications